Literature DB >> 21996378

Suspected transmission of tuberculosis in a maternity ward from a smear-positive nurse: preliminary results of clinical evaluations and testing of neonates potentially exposed, Rome, Italy, 1 January to 28 July 2011.

P Borgia1, A Cambieri, F Chini, L Coltella, G Delogu, E Di Rosa, G Fadda, P Giorgi Rossi, E Girardi, D Goletti, G Guasticchi, A Morrone, P Pezzotti, C Romagnoli, Mt Sacerdote, C Russo, A Villani, L Zarelli.   

Abstract

We report preventive measures adopted after tuberculosis(TB) transmission from a nurse to a newborn assessed in late July 2011. All exposed neonates born between January and July 2011 were clinically evaluated and tested by QuantiFERON TB gold in-tube; newborns testing positive were referred for prophylaxis.Of 1,340 newborns, 118 (9%) tested positive and no other active cases of TB were found. Active surveillance for TB will be continued over the next three years for all those exposed.

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21996378     DOI： 10.2807/ese.16.40.19984-en

Source DB:  PubMed          Journal:  Euro Surveill        ISSN： 1025-496X


  8 in total

1.  High rate of Quantiferon positive and tuberculin negative tests in infants born at a large Italian university hospital in 2011: a cautionary hypothesis.

Authors:  Antonio Cassone; Roberto Cauda; Andrea De Maria
Journal:  Pathog Glob Health       Date:  2012-03       Impact factor: 2.894

2.  Latent tuberculosis infection and associated risk factors among undergraduate healthcare students in Italy: a cross-sectional study.

Authors:  Paolo Durando; Giovanni Sotgiu; Fabio Spigno; Mauro Piccinini; Giovanni Mazzarello; Claudio Viscoli; Francesco Copello; Alessandro Poli; Filippo Ansaldi; Giancarlo Icardi
Journal:  BMC Infect Dis       Date:  2013-09-23       Impact factor: 3.090

3.  Latent tuberculosis infection among a large cohort of medical students at a teaching hospital in Italy.

Authors:  Paolo Durando; Cristiano Alicino; Andrea Orsi; Ilaria Barberis; Chiara Paganino; Guglielmo Dini; Giovanni Mazzarello; Valerio Del Bono; Claudio Viscoli; Francesco Copello; Dimitri Sossai; Giovanni Orengo; Laura Sticchi; Filippo Ansaldi; Giancarlo Icardi
Journal:  Biomed Res Int       Date:  2015-02-01       Impact factor: 3.411

Review 4.  Tuberculosis transmission from healthcare workers to patients and co-workers: a systematic literature review and meta-analysis.

Authors:  Monica Sañé Schepisi; Giovanni Sotgiu; Silvia Contini; Vincenzo Puro; Giuseppe Ippolito; Enrico Girardi
Journal:  PLoS One       Date:  2015-04-02       Impact factor: 3.240

5.  Performance of interferon-γ release assays in the diagnosis of confirmed active tuberculosis in immunocompetent children: a new systematic review and meta-analysis.

Authors:  Patrizia Laurenti; Matteo Raponi; Chiara de Waure; Marta Marino; Walter Ricciardi; Gianfranco Damiani
Journal:  BMC Infect Dis       Date:  2016-03-18       Impact factor: 3.090

6.  High rate of transmission in a pulmonary tuberculosis outbreak in a primary school, north-eastern Italy, 2019.

Authors:  Sandro Cinquetti; Maria Dalmanzio; Elisa Ros; Davide Gentili; Mauro Ramigni; Adriano Grossi; Xanthi D Andrianou; Leonardo Ermanno La Torre; Roberto Rigoli; Pier Giorgio Scotton; Angela Taraschi; Vincenzo Baldo; Giuseppina Napoletano; Francesca Russo; Patrizio Pezzotti; Giovanni Rezza; Antonietta Filia
Journal:  Euro Surveill       Date:  2019-06

7.  Risk Factors for Indeterminate Interferon-Gamma Release Assay for the Diagnosis of Tuberculosis in Children-A Systematic Review and Meta-Analysis.

Authors:  Noëmi R Meier; Thomas Volken; Marc Geiger; Ulrich Heininger; Marc Tebruegge; Nicole Ritz
Journal:  Front Pediatr       Date:  2019-05-29       Impact factor: 3.418

8.  Subcutaneous emphysema as the first relevant clinical sign of complicated tubercular lymph node disease in a child.

Authors:  Susanna Esposito; Alberto Giannini; Pietro Biondetti; Nicola Bonelli; Mario Nosotti; Samantha Bosis; Edoardo Calderini; Nicola Principi
Journal:  BMC Infect Dis       Date:  2013-10-04       Impact factor: 3.090
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.